A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Nancy L Bartlett Bruce D. Cheson Jane Winter Ranjana H. Advani |
| Publication date | June 12, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |